Total Payments
$5,601
2024 Payments
$645.11
Companies
28
Transactions
151
Medicare Patients
1,198
Medicare Billing
$104,654
Payment Breakdown by Category
Food & Beverage$5,601 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,601 | 151 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,666 | 56 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,040 | 15 | $0 (2024) |
| ABBVIE INC. | $813.30 | 13 | $0 (2024) |
| Abbott Laboratories | $366.06 | 13 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $267.92 | 4 | $0 (2019) |
| Lilly USA, LLC | $211.06 | 4 | $0 (2023) |
| PFIZER INC. | $193.43 | 6 | $0 (2023) |
| Corium, LLC | $125.00 | 1 | $0 (2022) |
| Dexcom, Inc. | $124.99 | 1 | $0 (2023) |
| Biohaven Pharmaceuticals, Inc. | $115.39 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $645.11 | 18 | AstraZeneca Pharmaceuticals LP ($360.55) |
| 2023 | $1,026 | 19 | AstraZeneca Pharmaceuticals LP ($241.09) |
| 2022 | $577.33 | 13 | Novo Nordisk Inc ($181.88) |
| 2021 | $1,190 | 13 | Novo Nordisk Inc ($499.99) |
| 2020 | $395.82 | 4 | AstraZeneca Pharmaceuticals LP ($245.19) |
| 2019 | $736.90 | 34 | Novo Nordisk Inc ($225.49) |
| 2018 | $690.52 | 30 | Novo Nordisk Inc ($151.62) |
| 2017 | $339.04 | 20 | Novo Nordisk Inc ($147.93) |
All Payment Transactions
151 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $112.20 | General |
| Category: Respiratory | ||||||
| 10/18/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $3.86 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $5.77 | General |
| Category: Obesity | ||||||
| 09/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Obesity | ||||||
| 06/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $96.13 | General |
| Category: Obesity | ||||||
| 06/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $2.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: Obesity | ||||||
| 05/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Cardio-renal | ||||||
| 05/07/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $86.31 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $3.82 | General |
| Category: Diabetes | ||||||
| 04/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $3.70 | General |
| Category: Diabetes | ||||||
| 04/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $7.10 | General |
| Category: Obesity | ||||||
| 03/27/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Diabetes Care | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $121.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $5.40 | General |
| Category: Obesity | ||||||
| 01/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.46 | General |
| Category: Obesity | ||||||
| 01/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $4.10 | General |
| Category: Obesity | ||||||
| 12/12/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.37 | General |
| Category: Obesity | ||||||
| 11/06/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $96.85 | General |
| Category: Diabetes Care | ||||||
| 11/06/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $5.50 | General |
| Category: Diabetes Care | ||||||
| 10/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $121.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $4.17 | General |
| Category: Obesity | ||||||
| 09/27/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: Diabetes | ||||||
| 08/16/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 235 | 334 | $46,810 | $22,166 |
| 2022 | 8 | 368 | 512 | $72,899 | $33,527 |
| 2021 | 6 | 307 | 485 | $65,305 | $30,803 |
| 2020 | 6 | 288 | 397 | $52,315 | $18,158 |
Total Patients
1,198
Total Services
1,728
Medicare Billing
$104,654
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 129 | 208 | $35,360 | $16,339 | 46.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 70 | $8,400 | $4,002 | 47.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 15 | 16 | $1,350 | $1,144 | 84.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 19 | 20 | $500.00 | $490.00 | 98.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 17 | 20 | $1,200 | $190.40 | 15.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 154 | 241 | $40,970 | $17,937 | 43.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 105 | 151 | $18,120 | $8,253 | 45.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 21 | 22 | $5,060 | $2,609 | 51.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 14 | 14 | $3,430 | $2,241 | 65.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 16 | 16 | $1,280 | $1,028 | 80.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 12 | 19 | $1,729 | $721.01 | 41.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 18 | 18 | $450.00 | $441.00 | 98.0% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 28 | 31 | $1,860 | $297.25 | 16.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 138 | 236 | $40,120 | $18,848 | 47.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 99 | 166 | $19,920 | $9,933 | 49.9% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 14 | 14 | $1,050 | $913.64 | 87.0% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 12 | 12 | $1,495 | $432.84 | 29.0% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 24 | 37 | $2,220 | $359.27 | 16.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 20 | 20 | $500.00 | $316.60 | 63.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 117 | 172 | $29,240 | $10,672 | 36.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 103 | 149 | $17,880 | $5,727 | 32.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 26 | 28 | $1,750 | $1,002 | 57.2% |
| 69210 | Removal of impact ear wax, one ear | Office | 2020 | 17 | 19 | $2,185 | $527.35 | 24.1% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 13 | 17 | $1,020 | $163.93 | 16.1% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 12 | 12 | $240.00 | $66.18 | 27.6% |
About Dr. Peter Stephan, MD
Dr. Peter Stephan, MD is a Family Medicine healthcare provider based in Kokomo, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1548266307.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Stephan, MD has received a total of $5,601 in payments from pharmaceutical and medical device companies, with $645.11 received in 2024. These payments were reported across 151 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($5,601).
As a Medicare-enrolled provider, Stephan has provided services to 1,198 Medicare beneficiaries, totaling 1,728 services with total Medicare billing of $104,654. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine, Family Medicine
- Location Kokomo, IN
- Active Since 06/24/2005
- Last Updated 08/03/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1548266307
Products in Payments
- FARXIGA (Drug) $807.57
- Saxenda (Drug) $597.32
- UBRELVY (Drug) $553.78
- Wegovy (Drug) $543.90
- AJOVY (Drug) $267.92
- MOUNJARO (Drug) $189.39
- Tresiba (Drug) $155.16
- Victoza (Drug) $134.98
- FREESTYLE LIBRE 3 (Device) $133.62
- FreeStyle Libre 2 (Device) $129.55
- PREVNAR 20 (Biological) $125.01
- AZSTARYS (Drug) $125.00
- RYBELSUS (Drug) $125.00
- DEXCOM G7 GSS (161) (Medical Supply) $124.99
- BREZTRI (Drug) $120.09
- QULIPTA (Drug) $117.92
- NURTEC ODT (Drug) $115.39
- AIRSUPRA (Drug) $112.20
- VRAYLAR (Drug) $109.19
- ACTIVAC (Device) $95.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Kokomo
Victoria Moyer, Md, MD
Family Medicine — Payments: $240,848
Family Medicine $240,848
Gregory Spangler, Md, MD
Family Medicine — Payments: $28,185
Family Medicine $28,185
Sheryar Sarwar, Md, MD
Family Medicine — Payments: $23,179
Family Medicine $23,179
Hardik Shah, Md, MD
Family Medicine — Payments: $9,649
Family Medicine $9,649
Josephine Lilla, M.d, M.D
Family Medicine — Payments: $8,884
Family Medicine $8,884
Sondi Beeler, Md, MD
Family Medicine — Payments: $8,512
Family Medicine $8,512